A Molecular Chaperone for Mitochondrial Complex I Assembly is Mutated in a Progressive Encephalopathy
Overview
Affiliations
NADH:ubiquinone oxidoreductase (complex I) deficiency is a common cause of mitochondrial oxidative phosphorylation disease. It is associated with a wide range of clinical phenotypes in infants, including Leigh syndrome, cardiomyopathy, and encephalomyopathy. In at least half of patients, enzyme deficiency results from a failure to assemble the holoenzyme complex; however, the molecular chaperones required for assembly of the mammalian enzyme remain unknown. Using whole genome subtraction of yeasts with and without a complex I to generate candidate assembly factors, we identified a paralogue (B17.2L) of the B17.2 structural subunit. We found a null mutation in B17.2L in a patient with a progressive encephalopathy and showed that the associated complex I assembly defect could be completely rescued by retroviral expression of B17.2L in patient fibroblasts. An anti-B17.2L antibody did not associate with the holoenzyme complex but specifically recognized an 830-kDa subassembly in several patients with complex I assembly defects and coimmunoprecipitated a subset of complex I structural subunits from normal human heart mitochondria. These results demonstrate that B17.2L is a bona fide molecular chaperone that is essential for the assembly of complex I and for the normal function of the nervous system.
Mitochondrial complex-1 as a therapeutic target for cardiac diseases.
Rai N, Venugopal H, Rajesh R, Ancha P, Venkatesh S Mol Cell Biochem. 2024; 480(2):869-890.
PMID: 39033212 DOI: 10.1007/s11010-024-05074-1.
Abu Hanna F, Zehavi Y, Cohen-Barak E, Khayat M, Warwar N, Shreter R Orphanet J Rare Dis. 2024; 19(1):92.
PMID: 38419071 PMC: 10900632. DOI: 10.1186/s13023-024-03094-0.
Using cryo-EM to understand the assembly pathway of respiratory complex I.
Laube E, Schiller J, Zickermann V, Vonck J Acta Crystallogr D Struct Biol. 2024; 80(Pt 3):159-173.
PMID: 38372588 PMC: 10910544. DOI: 10.1107/S205979832400086X.
Selheim F, Aasebo E, Bruserud O, Hernandez-Valladares M Cancers (Basel). 2024; 16(1).
PMID: 38201437 PMC: 10778527. DOI: 10.3390/cancers16010008.
Yin Z, Agip A, Bridges H, Hirst J EMBO J. 2024; 43(2):225-249.
PMID: 38177503 PMC: 10897435. DOI: 10.1038/s44318-023-00001-4.